DIAGNOSTIC POWER OF GENEXPERT MTB/RIF ASSAY FOR RAPID DIAGNOSIS OF TUBERCULOSIS AND DETECTION OF RIFAMPINCIN RESISTANCE IN SMEAR NEGATIVE SPUTUM SAMPLE OF SUSPECTED CASE OF TUBERCULOSIS IN TERTIARY CARE HOSPITAL, JAMNAGAR, GUJARAT

S.C. GAMIT1, H.K. SHINGALA2*, S. MULLAN3
1Department of Microbiology, M.P.Shah Govt. Medical College, Jamnagar, 361008, Saurashtra University, Rajkot, 360 005, Gujarat, India
2Department of Microbiology, M.P.Shah Govt. Medical College, Jamnagar, 361008, Saurashtra University, Rajkot, 360 005, Gujarat, India
3Department of Microbiology, M.P.Shah Govt. Medical College, Jamnagar, 361008, Saurashtra University, Rajkot, 360 005, Gujarat, India
* Corresponding Author : hitesh_shingala@yahoo.com

Received : 03-05-2019     Accepted : 26-05-2019     Published : 30-05-2019
Volume : 11     Issue : 5       Pages : 1561 - 1564
Int J Microbiol Res 11.5 (2019):1561-1564

Keywords : Mycobacterium tuberculosis, GeneXpert MTB/RIF Assay, Smear negative sputum, Rifampicin, HIV positive
Conflict of Interest : None declared
Acknowledgements/Funding : Authors are thankful to Department of Microbiology, M.P.Shah Govt. Medical College, Jamnagar, 361008, Saurashtra University, Rajkot, 360 005, Gujarat, India
Author Contribution : All authors equally contributed

Cite - MLA : GAMIT, S.C., et al "DIAGNOSTIC POWER OF GENEXPERT MTB/RIF ASSAY FOR RAPID DIAGNOSIS OF TUBERCULOSIS AND DETECTION OF RIFAMPINCIN RESISTANCE IN SMEAR NEGATIVE SPUTUM SAMPLE OF SUSPECTED CASE OF TUBERCULOSIS IN TERTIARY CARE HOSPITAL, JAMNAGAR, GUJARAT ." International Journal of Microbiology Research 11.5 (2019):1561-1564.

Cite - APA : GAMIT, S.C., SHINGALA, H.K., MULLAN, S. (2019). DIAGNOSTIC POWER OF GENEXPERT MTB/RIF ASSAY FOR RAPID DIAGNOSIS OF TUBERCULOSIS AND DETECTION OF RIFAMPINCIN RESISTANCE IN SMEAR NEGATIVE SPUTUM SAMPLE OF SUSPECTED CASE OF TUBERCULOSIS IN TERTIARY CARE HOSPITAL, JAMNAGAR, GUJARAT . International Journal of Microbiology Research, 11 (5), 1561-1564.

Cite - Chicago : GAMIT, S.C., H.K. SHINGALA, and S. MULLAN. "DIAGNOSTIC POWER OF GENEXPERT MTB/RIF ASSAY FOR RAPID DIAGNOSIS OF TUBERCULOSIS AND DETECTION OF RIFAMPINCIN RESISTANCE IN SMEAR NEGATIVE SPUTUM SAMPLE OF SUSPECTED CASE OF TUBERCULOSIS IN TERTIARY CARE HOSPITAL, JAMNAGAR, GUJARAT ." International Journal of Microbiology Research 11, no. 5 (2019):1561-1564.

Copyright : © 2019, S.C. GAMIT, et al, Published by Bioinfo Publications. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Abstract

Tuberculosis is a widespread, infectious disease caused by various strains of Mycobacteria usually Mycobacterium tuberculosis. Tuberculosis typically attacks the lungs and can also affect other parts of the body. An active TB infected patient’s cough, sneeze, or otherwise transmit through respiratory fluids are the common cause for the TB through the air. This study, which was conducted in tertiary care hospital, Jamnagar. There were 2 sputum samples, one spot supervised and one early morning collected and transported from various centres to TB culture-DST laboratory, Total 448 Smear Negative Sputum (Suspected case of Mycobacterium tuberculosis) samples were received during the study period and proceeded by GeneXpert MTB/RIF Assay. Out of total 448 smear negative sputum samples, in 142 sputum samples Mycobacterium tuberculosis Bacilli (MTB) were detected, Out MTB positive cases 12(8.45%) sputum samples resistant to Rifampicin and 103(72.53%) and 39(27.47%) cases from male and female gender respectively. highest number of MTB positive cases were found in age group of 21-30 years which were 38(26.8%) followed by 31-40 years which were 37(26%). Out total 448 Smear Negative Sputum 74 HIV positive sputum samples, in 18 samples Mycobacterium tuberculosis Bacilli (MTB) were detected. The study revealed the GeneXpert MTB/RIF Assay test offers a potential solution for improving early MTB diagnosis.

References

1. Lawn S.D; Zumla A.I.( 2011) Lancet, 378(9785), 57-72.
2. Rothschild B.M., Martin L.D.,Lev G.,et al.( 2001) Clin.Infect.Dis.,33(3),305-11.
3. Park K., Text book of preventive and social medicine, 20th edition Epidemiology of communicable diseases, Tuberculosis, Page-159.
4. Dolin (edited by) Gerald L. Mandell, john E. Bennett, Raphael (2010) Mandellduglas, and benntt’s principles and practice of infectious disease (7th ed.) Philadelphia, PA: Churchill livingtone/Elsevier.Pp.Chapter 250 ISBN 978-0443-06839-3.
5. O.’Brian R. (1994) Semin Respir Infect., 9(2), 104-12.
6. Xpert MTB/RIF system for the diagnosis of pulmonary and extrapulmonaryTB and rifampicin resistance in adults and children. A pre-publication version of the policy guidance may be accessed at: http://www.stoptb.org/wg/gli/assets/documents/WHO Policy Statement on Xpert MTB-RIF 2013 pre-publication 22102013.pdf
7. The full Expert Group meeting report is available at: http://www.stoptb.org “ WHO says Cepheid rapid test will transform TB care”. Reuters. 8th December 2010.
8. GeneXpert Dx System Operator Manual, 301-0045 Rev. C, June 2012 Cepheid.
9. Raviglione Mario (2006) The Intranational Journal of Tuberculosis and Lung Disease,10,1185-87(3).
10. Reechaipichitkul W. et al. (2016) Southeast Asian J Trop Med Public Health. 2016.
11. Poojan Shrestha, Amit Arjyal, Maxine Caws, Krishna Govinda Prajapati, Abhilasha Karkey, Sabina Dongol, Saruna Pathak, Shanti Prajapati and Buddha Basnyat, (2015) Tuberculosis Research and Treatment, Article ID 102430, 6 pages.
12. Thapa A., Gurung P., Ghimire G.R. (2017) SAARC Journal of Tuberculosis, lung diseases and HIV/AIDS, 13 (1), 16-22.
13. Raghuprakash Reddy and Gerardo Alvarez-Uria (2017) Journal of Pathogens, Article ID 6738095, 5 pages.
14. Sepiso K. Masenga, Harrison Mubila and Benson M. Hamooya (2017) BMC Infect Dis., 17, 640.
15. Okonkwo R.C., Onwunzo M.C., Chukwuka C.P., et al. (2017) J. HIV Retrovirus, 3,1.
16. Dhanya P.R., Shilpa K., Manjesh M. (2018) International Journal of Medicine Research, 3(2), 01-05.